Akebia Therapeutics (AKBA) Goodwill & Intangibles (2018 - 2026)

Akebia Therapeutics (AKBA) has 9 years of Goodwill & Intangibles data on file, last reported at $59.0 million in Q1 2026.

• On a quarterly basis, Goodwill & Intangibles changed 0.0% year-over-year to $59.0 million in Q1 2026; TTM through Mar 2026 was $59.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $59.0 million, changed 0.0% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $59.0 million, roughly flat from $59.0 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for AKBA reached as high as $158.2 million in Q1 2022 and fell as low as $59.0 million in Q2 2025.
• Historically, Goodwill & Intangibles has averaged $94.0 million across 5 years, with a median of $86.0 million in 2024.
• Across the five-year window, Goodwill & Intangibles sank 37.9% in 2024 and changed 0.0% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $131.1 million in 2022, then decreased by 27.46% to $95.1 million in 2023, then sank by 37.9% to $59.0 million in 2024, then changed by 0.0% to $59.0 million in 2025, then changed by 0.0% to $59.0 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $59.0 million in Q1 2026, $59.0 million in Q4 2025, and $59.0 million in Q3 2025.